TGTX – tg therapeutics, inc. (US:NASDAQ)
Stock Stats
News
TG Therapeutics, Inc. (NASDAQ: TGTX) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
TG Therapeutics, Inc. (NASDAQ: TGTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $55.00 price target on the stock.
TG Therapeutics says 2024 Briumvi sales topped expectations [Seeking Alpha]
TG Therapeutics Provides Preliminary Fourth Quarter and Full Year 2024 Net Revenue and 2025 Anticipated Development Milestones [Yahoo! Finance]
TG Therapeutics Provides Preliminary Fourth Quarter and Full Year 2024 Net Revenue and 2025 Anticipated Development Milestones
Form 4 TG THERAPEUTICS, INC. For: Jan 29 Filed by: WEISS MICHAEL S
Form 4 TG THERAPEUTICS, INC. For: Jan 29 Filed by: Power Sean A
Form 8-K TG THERAPEUTICS, INC. For: Jan 14
Form SCHEDULE 13G/A TG THERAPEUTICS, INC. Filed by: VANGUARD GROUP INC
Form 4 TG THERAPEUTICS, INC. For: Jan 03 Filed by: Power Sean A
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.